Pierre R. Breber Purchases 4,000 Shares of The Clorox Company (NYSE:CLX) Stock

The Clorox Company (NYSE:CLX) Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director now owns 4,000 shares of the company’s stock, valued at approximately $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Clorox Stock Down 2.2%

Shares of NYSE CLX opened at $134.79 on Monday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market cap of $16.60 billion, a PE ratio of 36.83, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a 50-day moving average of $142.37 and a 200 day moving average of $154.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the prior year, the company posted $1.71 EPS. The firm’s revenue was down 8.0% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were paid a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.62%. Clorox’s dividend payout ratio is presently 87.61%.

Institutional Trading of Clorox

Several large investors have recently bought and sold shares of CLX. Norges Bank purchased a new stake in Clorox during the 4th quarter valued at about $259,041,000. FMR LLC grew its stake in shares of Clorox by 75.4% in the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after buying an additional 585,526 shares during the period. KBC Group NV grew its stake in shares of Clorox by 688.7% in the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after buying an additional 513,171 shares during the period. Marshall Wace LLP grew its stake in shares of Clorox by 549.8% in the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock valued at $88,144,000 after buying an additional 459,203 shares during the period. Finally, ExodusPoint Capital Management LP grew its stake in shares of Clorox by 187.9% in the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock valued at $113,508,000 after buying an additional 456,114 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. DA Davidson decreased their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Wells Fargo & Company decreased their price objective on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Citigroup reduced their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday, April 14th. Finally, UBS Group reduced their price target on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $151.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.